Observational study of trastuzumab biosimilar in patients with HER2-positive breast cancer under routine clinical practice conditions in Morocco
- DOI
- 10.1186/s12885-026-16005-2
- Published
- 2026-04-28
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-026-16005-2,
title = {Observational study of trastuzumab biosimilar in patients with HER2-positive breast cancer under routine clinical practice conditions in Morocco},
author = {Hassan Errihani and Narjiss Berrada and Meryem El Bachiri and Hassan Jouhadi and Omar Kabbaj and Mouna Bourhafour and Abdellatif Benider and Mouna Khouchani and Ghizlane Belbaraka and Abdelkader Acharki and Redouane Samlali and Kunvar Harsh Upveja},
year = {2026},
journal = {BMC Cancer},
doi = {10.1186/s12885-026-16005-2},
url = {https://doi.org/10.1186/s12885-026-16005-2}
}RIS
TY - JOUR TI - Observational study of trastuzumab biosimilar in patients with HER2-positive breast cancer under routine clinical practice conditions in Morocco AU - Hassan Errihani AU - Narjiss Berrada AU - Meryem El Bachiri AU - Hassan Jouhadi AU - Omar Kabbaj AU - Mouna Bourhafour AU - Abdellatif Benider AU - Mouna Khouchani AU - Ghizlane Belbaraka AU - Abdelkader Acharki AU - Redouane Samlali AU - Kunvar Harsh Upveja PY - 2026 JO - BMC Cancer DO - 10.1186/s12885-026-16005-2 UR - https://doi.org/10.1186/s12885-026-16005-2 ER -
APA
Errihani, H., Berrada, N., Bachiri, M. E., Jouhadi, H., Kabbaj, O., Bourhafour, M., Benider, A., Khouchani, M., Belbaraka, G., Acharki, A., Samlali, R., & Upveja, K. H. (2026). Observational study of trastuzumab biosimilar in patients with HER2-positive breast cancer under routine clinical practice conditions in Morocco. BMC Cancer. https://doi.org/10.1186/s12885-026-16005-2
Source records
- crossref · retrieved 2026-09-25T10:43:03.744Z